Skip to main content
Ora
About Us
Our Clients
Areas of Expertise
Clinical Models
Preclinical Models
Our Services
Contact
Careers
News & Publications
Posters
Events
Ora Investigator Network
Participate in a Clinical Trial
Ora Newsletter
Ora Japan
Allergic Rhinitis
(24)
Allergy
(71)
Anti-Infective
(36)
Anti-Inflammatory
(35)
Devices
(27)
Drug Delivery
(20)
Dry Eye
(125)
Glaucoma
(27)
Retina
(68)
Corporate News
(47)
Other Specialty
(48)
Ora Newsletter Sign-up Today
*
Previous issues
Posters
Evaluation of the Effects of SkQ1 in Ora’s Rabbit Anterior Chamber Paracentesis Model
The effect of TRPM8-agonist Menthol Eyedrops on Tear Meniscus Area and Height
Reducing Nasal and Ocular Itching with a Novel Drug in the Allergen BioCube
more posters
Articles
Veeva Vault CTMS Gains Momentum as Industry Moves to Unify Clinical Applications and Processes
Nicox receives FDA approval of ZERVIATE (cetirizine ophthalmic solution) 0.24%
Dry Eye: Beyond the Usual Suspects
more articles
All Posters
From
Retina
ARVO
Assessment of Macular Recovery Time after Photostress by Foveal L-Cone Dark Adaptation in Young...
ARVO - 2010
From
Retina
ARVO
Time trends in the Prevalence of Diabetic Retinopathy in Persons With Type 1 and Type 2 Diabetes
2009_ARVO_Time_Trends_in_the_Prevalence_of_Diabetic_Retinopathy.pdf
From
Dry Eye
ARVO
Symptomatic Break-up Time (SBUT) in Dry Eye Patients with Normal vs. Low Corneal Sensitivity
ARVO - 2009
From
Dry Eye
ARVO
Modification of Tear Film Break-up Pattern in the Controlled Adverse Environment (CAE) Model
2009_ARVO_Modification _of_Tear_Film_Breakup_Pattern.pdf
From
Allergic Rhinitis
ARVO
Evaluation of Daily Oculat and Nasal Allergic Signs and Symptoms During 4 Weeks of Ragweed Season...
ARVO - 2009
From
Dry Eye
ARVO
Effects of Lacrisery on the signs and symptoms of dry eye in contact lens wearers
ARVO - 2009
From
Retina
ARVO
Current Pipeline for Treatment of Diabetic Retinopathy
ARVO - 2009
Pages
« first
‹ previous
1
2
3
4
5
6
7
